COVID-19 variants that escape vaccine immunity: Global and Indian context-are more vaccines needed?
Ontology highlight
ABSTRACT: The COVID-19 pandemic that emerged around December 2019 claimed millions of lives. For vaccine development, S protein on viral envelope that binds to ACE2 receptor on cells for entry was identified as vaccine candidate. S protein consists of Receptor Binding Motif (RBM) in the S1 subunit followed by the S2 subunit with an intermediate furin cleavage site. A stabilized version of S protein with 2 proline residues was used as antigen. Overall, most vaccines exhibited efficacy between 80 and 95%. However, being a RNA virus that is prone to mutations along with selection pressure on S protein and frequent use of convalescent plasma led to evolution of variants. These variants are responsible for multiple waves of infection observed globally. In our review, we discuss current data on vaccines a
SUBMITTER: Deb B
PROVIDER: S-EPMC8633907 | biostudies-literature | 2021
REPOSITORIES: biostudies-literature
ACCESS DATA